You can buy or sell KZR and other stocks, options, and ETFs commission-free!
Kezar Life Sciences, Inc. Common Stock, also called Kezar Life Sciences, is a clinical-stage biotechnology company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco, California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA. The listed name for KZR is Kezar Life Sciences, Inc. Common Stock.
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Mar 11, After Hours